AJU IB Investment Co., Ltd.

Position in XLO — Xilio Therapeutics, Inc.

CIK 1710065 Seoul, M5

Position in XLO

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$401,114

-$5,581,854 QoQ

Shares Held

47,695

-92.9% QoQ

Ownership

0.825%

of shares outstanding

% of Portfolio

1.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AJU IB Investment Co., Ltd. holds $29,915,942 across 5 Biotechnology names. XLO ranks #5 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	223,486	$25,660,662
2	KYMR	Kymera Therapeutics, Inc.	19,648	$1,636,481
3	SEER	Seer, Inc.	816,375	$1,371,510
4	RLYB	Rallybio Corp	94,334	$846,175
5	XLO	Xilio Therapeutics, Inc. This page	47,695	$401,114

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$401,114	47,695	-92.9%	Shares	Sole	2026-05-08
2025-12-31	$5,982,968	667,742	0.0%	Shares	Sole	2026-02-10
2025-09-30	$7,880,691	667,742	0.0%	Shares	Sole	2025-11-06
2025-06-30	$6,356,903	667,742	0.0%	Shares	Sole	2025-07-10
2025-03-31	$6,768,232	667,742	0.0%	Shares	Sole	2025-04-08
2024-12-31	$8,927,710	667,742	0.0%	Shares	Sole	2025-04-08
2022-09-30	$27,203,809	667,742	0.0%	Shares	Sole	2022-11-14
2022-06-30	$27,297,292	667,742	0.0%	Shares	Sole	2022-08-09
2022-03-31	$66,093,103	667,742	0.0%	Shares	Sole	2022-05-12
2021-12-31	$149,574,208	667,742	—	Shares	Sole	2022-02-09
No filing history on record for this holder in this stock.